Abstract 1468: NUV-655 (NVL-655) is a selective, brain-penetrant ALK inhibitor with antitumor activity against the lorlatinib-resistant G1202R/L1196M compound mutation Kirk SmithApril 21, 2022 Facebook0 Twitter LinkedIn0 0 Likes